Vancomycin Hydrochloride
Vancomycin Hydrochloride for Injection, USP (For Intravenous Use)
Approved
Approval ID
8403695c-3614-490b-9797-6c5ebcdeef9b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 12, 2023
Manufacturers
FDA
Xellia Pharmaceuticals USA LLC
DUNS: 116768762
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
vancomycin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70594-122
Application NumberANDA205694
Product Classification
M
Marketing Category
C73584
G
Generic Name
vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 12, 2023
FDA Product Classification
INGREDIENTS (1)
VANCOMYCIN HYDROCHLORIDEActive
Quantity: 500 mg in 1 1
Code: 71WO621TJD
Classification: ACTIM
vancomycin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70594-123
Application NumberANDA205694
Product Classification
M
Marketing Category
C73584
G
Generic Name
vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 12, 2023
FDA Product Classification
INGREDIENTS (1)
VANCOMYCIN HYDROCHLORIDEActive
Quantity: 1 g in 1 1
Code: 71WO621TJD
Classification: ACTIM